Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
inflammation
Pharma
Amgen, AZ eye Tezspire expansion after detailed EoE ph. 3 win
AZ and Amgen are now eyeing regulatory filings for Tezspire, in what would mark the first major challenge to Sanofi and Regeneron’s Dupixent in EoE.
Fraiser Kansteiner
Oct 20, 2026 9:00am
Fierce Biotech
CEO O’Day tells Fierce how Gilead reached ‘critical mass’
Sep 16, 2026 8:00am
Fierce Biotech
JPM26: Gilead eyes new deals from a 'position of strength'
Jan 14, 2026 3:30am
InflaRx charts layoffs, cost cuts to lift lead asset's prospects
Jan 8, 2026 11:03am
New treatments needed in chronic hand eczema: GlobalData
Dec 19, 2024 3:35pm
Apellis homes in on possible source of rare Syfovre side effect
Aug 23, 2023 9:28am